A detailed history of Grant transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Grant holds 7,858 shares of EW stock, worth $587,856. This represents 0.26% of its overall portfolio holdings.

Number of Shares
7,858
Previous 7,958 1.26%
Holding current value
$587,856
Previous $735,000 29.52%
% of portfolio
0.26%
Previous 0.38%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$59.7 - $93.78 $5,970 - $9,378
-100 Reduced 1.26%
7,858 $518,000
Q2 2024

Jul 22, 2024

SELL
$84.3 - $94.31 $8,430 - $9,431
-100 Reduced 1.24%
7,958 $735,000
Q1 2024

Apr 25, 2024

SELL
$72.54 - $95.56 $2,393 - $3,153
-33 Reduced 0.41%
8,058 $770,000
Q4 2023

Jan 30, 2024

SELL
$61.71 - $77.76 $21,598 - $27,216
-350 Reduced 4.15%
8,091 $616,000
Q3 2023

Oct 24, 2023

SELL
$69.28 - $93.38 $2,078 - $2,801
-30 Reduced 0.35%
8,441 $584,000
Q2 2023

Jul 19, 2023

BUY
$81.41 - $94.33 $689,624 - $799,069
8,471 New
8,471 $799,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $8,237 - $10,729
-100 Reduced 1.13%
8,740 $749,000
Q4 2021

Jan 13, 2022

SELL
$106.37 - $130.68 $10,637 - $13,068
-100 Reduced 1.12%
8,840 $1.08 Million
Q4 2020

Jan 15, 2021

BUY
$71.69 - $91.23 $640,908 - $815,596
8,940 New
8,940 $797,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Grant Portfolio

Follow Grant and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant, based on Form 13F filings with the SEC.

News

Stay updated on Grant with notifications on news.